InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by KELLOGG PETER N. Officer active across 2 companies, notably ALNYLAM PHARMACEUTICALS, INC.. In total, 4 reports have been recorded. Activity tracked since 8 May 2025. The latest transaction was filed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations